Government cuts in Addiction

Government funding cuts to addiction programs have created significant challenges for individuals and communities seeking recovery support. These reductions have led to the closure or downsizing of treatment centers, fewer harm reduction services, and limited access to medication-assisted treatment and peer support. As formal services become harder to reach, the role of self-management becomes more … Read more

Scams in SUD Treatment Facilities

SUD treatment scams target vulnerable people with false promises. Government rules enforce licensing, ban kickbacks, and control ads. Individuals protect themselves by researching and tracking choices. Families and community groups guide toward safe, ethical care, helping prevent exploitation and support recovery. Avoiding Deceptive Practices in SUD Treatment: A Guide for Families and Patients ✅ Ways … Read more

Refusing to offer MAT

Denying MAT access is seen as both negligent and a civil rights violation under laws like the ADA. Facilities may face consequences for restricting or withholding MAT. Families can advocate through legal action and support networks, with help from legal aid and peer advocates. The High Cost of Denying MAT: Why Withholding Evidence-Based Addiction Treatment … Read more

Repurposing Drugs in Addiction

Repurposing existing drugs for addiction offers faster, low-cost treatment options but faces challenges like limited evidence, safety risks, low industry interest, and ethical concerns. Government agencies help guide regulation, research, and access. Repurposed Medications for Addiction Treatment Repurposing existing medications—originally developed for other health conditions—is a promising and efficient strategy in addiction treatment. Since many … Read more

Changes in Addiction Treatment

As addiction treatment policy shifts under the Trump administration, there is a growing emphasis on state control, reduced federal funding, and a law enforcement-focused approach over public health. These changes may limit access to evidence-based care, especially for vulnerable groups relying on Medicaid or community services. In response, stakeholders must advocate for treatment access, equitable … Read more

ER Opioid Treatment Barriers

Many ERs face barriers to treating opioid use disorder (OUD), due to lack of protocols, limited training, and poor care coordination. While hospitals work to improve systems, patients and families can take action now. Using clear self-advocacy and family support strategies, they can request evidence-based care—like buprenorphine—and improve access to treatment during ER visits. Why … Read more

Health Equity in Addiction Therapy

Equity in addiction treatment ensures that all individuals, regardless of background or circumstances, have access to fair and effective care. However, systemic barriers like discrimination, financial limitations, and lack of culturally competent care often create inequities. To address this, self-management practices, family support, and community resource strategies are key. Self-management empowers individuals in their recovery, … Read more

Medication Prior Authorization

Prior authorization (PA) is used by insurance companies to approve healthcare services, including medications and therapies. While it aims to control costs, PA can delay care and create administrative challenges, especially in addiction treatment. Self-management strategies help individuals navigate the process, while family support provides advocacy. Community resources, such as publicly funded programs and integrated … Read more

Addiction Deflection Program

A deflection program redirects individuals with substance use disorders from the justice system to treatment, treating addiction as a health issue. While beneficial, challenges include limited access, funding issues, and ethical concerns. Success depends on commitment to recovery and family support, which enhance long-term outcomes. Breaking the Cycle: How Addiction Deflection Programs Offer a Path … Read more

Addiction Genetic-Based Therapy

Genetic-based therapy for addiction personalizes treatment by analyzing an individual’s genetic makeup, aiming to improve effectiveness through tailored interventions like pharmacogenomics. Driven by research on genetic influences in addiction, this approach offers potential benefits but also raises ethical concerns, privacy risks, and the challenge of overemphasizing genetics over psychological and social factors. While promising, its … Read more